Alpha Tau Medical Ltd.
DRTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $378 | $251 | $177 | $217 |
| - Cash | $3 | $12 | $5 | $14 |
| + Debt | $14 | $13 | $12 | $13 |
| Enterprise Value | $388 | $252 | $184 | $216 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$9 | -$9 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$10 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | -0.13 | -0.12 | -0.14 |
| % Growth | -7.7% | -8.3% | 14.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |